2039-96-5

Usage

Uses

Used in NMR Spectroscopy:
3-(TRIMETHYLSILYL)-1-PROPANESULFONIC ACID SODIUM SALT is used as an internal NMR standard for deuterated water (D2O). Its application is crucial in ensuring accurate and reliable measurements in NMR spectroscopy, a technique widely used in chemistry and biochemistry to study the structure and dynamics of molecules.
The compound serves as a reference point for chemical shifts, allowing researchers to compare and analyze the NMR signals of other molecules in the sample. Its solubility in D2O makes it an ideal choice for studies involving aqueous solutions or samples that require deuterium oxide as a solvent.

InChI:InChI=1/C6H16O3SSi/c1-11(2,3)6-4-5-10(7,8)9/h4-6H2,1-3H3,(H,7,8,9)

Upstream product

• 18546-65-1 tris(trimethylsilylpropyl)aluminium 

Relevant academic research and scientific papers

ALUMINIUMALKYLE MIT HETEROATOMEN. XI. UEBER DIE UMSETZUNG VON SCHWEFELTRIOXID MIT TRIS(SILYLALKYL)ALUMINIUM-VERBINDUNGEN ZU SILYLALKANSULFONATEN

Treatment of sulphur trioxide with tris(silylalkyl)aluminium compounds followed by hydrolysis and extraction with ethyl alcohol is a new method for preparation of substituted sodium silylalkane sulphonates.Weak donor-acceptor complexes of the starting compounds react selectively with insertion at the aluminium-carbon bond without cleavage of the silicon-carbon bond.The structure of the silylalkane sulphonates is determined by 1H NMR and IR spectroscopy.

Sesquiterpene derivatives having anti-complementary activity

A sesquiterpene derivative expressed by the general formula (I): STR1 wherein R1 represents a hydrogen atom, a lower alkyl group or a lower alkanoyl group; R2 and R3, which may be the same or different, each represents a formyl group, a hydroxymethyl group, a hydroxyl group, a carboxyl group, a lower alkanoyloxymethyl group, or a group of the formula --CH=CR7 R8, wherein R7 and R8, which may be the same or different, each represents a hydrogen atom, a cyano group, a lower alkoxycarbonyl group or a carboxyl group, or R2 and R3 may combine to form a lactone ring of the formula STR2 in which R9 represents a hydrogen atom or a hydroxyl group; R4 and R6, which may be the same or different, each represents a hydroxyl group or a lower alkanoyloxy group; R5 represents a hydrogen atom; R4 and R5 may together form an oxo group (=O); and R4 and R6 may combine to form a lower alkylidenedioxy group, the pharmaceutically acceptable salts thereof, processes for the production of the compounds of the general formula (I) and the salts thereof, pharmaceutical composition containing the compounds of the general formula (I) and the salts thereof, and method of use of the compounds of the general formula (I) and the salts thereof.